Mustafa Mohammed

Mr. Mustafa Mohammed

orcid

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2026 in Technologies
Verified
Journal Article
Open access
PDF file
AAAhmad R. Alsayed
Ahmad R. Alsayed
MAMohanad Al-Darraji
Mohanad Al-Darraji
MAMohannad Omar Alqaiseiah
Mohannad Omar Alqaiseiah
ASAnas Samara
Anas Samara
MMMustafa Mohammed
Mustafa Mohammed
Geriatric pharmacotherapy is usually challenged by physiological senescence. For instance, progressive declines in organ function and alterations in body composition can complicate drug disposition. However, conventional pharmacometrics models commonly have limited capacity to map these high-dimensional, nonlinear relationships. In this review, we are examining the recent shift toward integrating machine learning (ML) with mechanistic pharmacokinetic (PK)/pharmacodynamic (PD) models to improve the accuracy and precision of dosing. Machine learning approaches like Random Forest and XGBoost consistently provided more accurate exposure predictions and significantly more efficient computational workflows than conventional methods. Nevertheless, concerns such as “black box” transparency and the potential of algorithmic bias toward specific patient demographics are challenging. It is important to incorporate explainability tools like SHAP, and adopting FAIR data principles is crucial for achieving professional trust and ensuring site-specific generalizability.

6 April 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
AAAhmad R. Alsayed
Ahmad R. Alsayed
MAMohanad Al-Darraji
Mohanad Al-Darraji
MAMohannad Omar Alqaiseiah
Mohannad Omar Alqaiseiah
ASAnas Samara
Anas Samara
MMMustafa Mohammed
Mustafa Mohammed
Geriatric pharmacotherapy is usually challenged by physiological senescence. For instance, progressive declines in organ function and alterations in body composition can complicate drug disposition. However, conventional pharmacometrics models commonly have limited capacity to map these high-dimensional, non-linear relationships. In this review, we are examining the recent shift toward integrating Machine Learning (ML) with mechanistic Pharmacokinetic (PK)/Pharmacodynamic (PD) models to improve the accuracy and precision of dosing. Machine learning approaches like Random Forest and XGBoost consistently provided more accurate exposure predictions and significantly more efficient computational workflows than conventional methods. Nevertheless, concerns such as "black box" transparency and the potential of algorithmic bias toward specific patient demographics are challenging. It is important to incorporate explainability tools like SHAP, and adopting FAIR data principles is crucial for achieving professional trust and ensuring site-specific generalizability.